Thursday, July 1, 2010

Cushing’s Blog Alerts ~ July 1, 2010

Cushing's & Cancer: Cushing's Syndrome and Receiving Social ...
By MaryO
Cushing's syndrome is a relatively rare disorder. It usually happens to adults between the ages of 20 and 50. An estimated 10 to 15 out of every million people in the United States are affected by it each year. ...
Cushing's & Cancer - http://cushingshelp.blogspot.com/

Day 182 in the life of a (former) Cushing's patient - 365 days ...
I am offended by the above slide and accompanying audio from a presentation by a supposed Cushing's expert. I have good reason to add the "supposed". To read more about the origins of this slide and how/when it was presented (including ...
365 days with Cushing's Disease - http://cushings365.posterous.com/

NCLEX Question Cushing's Syndrome | July 2010 Nursing Board Exam ...
By Postagent
Sample Test Question For Cushing's Syndrome,Sample NCLEX Question,NCLEX Question with rationale,Free NCLEX QUestion.
July 2010 Nursing Board Exam... - http://nursingbuzz.com/

survive the journey: I am offended.
By survivethejourney@gmail.com (RobinS)
In February, the Cushing's Support and Research Foundation (CSRF) hosted a Cushing's Patient Education Day. I was not able to go either physically or financially at the time. This was sponsored by an unrestricted educational grant from ...
survive the journey - http://survivethejourney.blogspot.com/

What Causes Hypertension in Cushing's Syndrome? | All About ...
Having trouble understanding exactly what causes raised blood pressure in Cushing's syndrome. The closest I've gotten thus far is that hypertension in.
www.all-about-hypertension.com/.../what-causes-hypertension...

Cushing's Syndrome/ Buffalo Hump.
Has anyone had any experience here with Cushing's Syndrome?. Somebody mentioned to me on Curezone and since then it's been on the back of my mind.
immortalhair.forumandco.com/.../cushing-s-syndrome-buffalo...

Corcept Therapeutics Nears Completion of Enrollment in Phase 3 ...
"We are near our target of dosing 50 patients in our Phase 3 study of CORLUX for the treatment of Cushing's Syndrome. We remain on track to announce top ...
online.wsj.com/article/PR-CO-20100625-901917.html

Post a Comment